ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Promoting the Recruitment, Engagement, and Reinvigoration of Effector T Cells via an Injectable Hydrogel with a Supramolecular Binding Capability for Cancer Immunotherapy

Zhu, Yueqiang; Jin, Liangjie; Chen, Junbin; Su, Miao; Sun, Tianmeng; Yang, Xianzhu*吉林大学; 1
Advanced Materials2023-10-18DOI: 10.1002/adma.202309667
1被引4阅读
引用收藏
分享

摘要

T cells play a basic and key role in immunotherapy against solid tumors, and efficiently recruiting them into neoplastic foci and sustaining long-term effector function are consistent goals that remain a critical challenge. Here, an injectable alginate-based hydrogel with abundant beta-cyclodextrin (ALG-beta CD) sites is developed and intratumorally injected to recruit CCR9(+)CD8(+ )T cells (a subset of T cells with robust antitumor activity) via the trapped chemokine CCL25. In the meantime, an intravenously injected adamantane-decorated anti-PD1 antibody (Ad-aPD1) would hitchhike on recruited CCR9(+)CD8(+) T cells to achieve the improved intratumoral accumulation of Ad-aPD1. Moreover, the Ad-PD1 and Ad-PDL1 antibodies are immobilized in the ALG-beta CD hydrogel through supramolecular host-guest interactions of Ad and beta CD, which facilitate engagement between CD8(+) T cells and tumor cells and reinvigorate CD8(+) T cells to avoid exhaustion. Based on this treatment strategy, T cell-mediated anticancer activity is promoted at multiple levels, eventually achieving superior antitumor efficacy in both orthotopic and postsurgical B16-F10 tumor models.

学科与关键词

关键词
cancer immunotherapyengagement between T cells and tumor cellsrecruiting CCR9(+)CD8(+) T cellsreinvigoration of CD8(+) T cellssupramolecular bindingT cell hitchhiking
相关
加载中…
  • Injectable Hydrogel as a Unique Platform for Antitumor Therapy Targeting Immunosuppressive Tumor Microenvironment
    Liu, Yushuai; Geng, Yuanyuan; Yue, Beilei; Lo, Pui-Chi; Huang, Jing*; Jin, Honglin*Frontiers in Immunology, 2022, 13: 832942.被引 16
  • Injectable Supramolecular Hydrogel for Locoregional Immune Checkpoint Blockade and Enhanced Cancer Chemo-Immunotherapy
    Liu, Mengting; Cao, Ziyang; Zhang, Runlin; Chen, Yunhua; Yang, Xianzhu*ACS applied materials & interfaces, 2021, 13(29): 33874-33884.被引 32
  • Suppression of cytokine release syndrome during CAR-T-cell therapy via a subcutaneously injected interleukin-6-adsorbing hydrogel
    Li, Xianlei; Gong, Ningqiang*; Tian, Falin; Zhang, Shangkun; Zhang, Yuxuan; Wang, Yufei; Qing, Guangchao; Wang, Yongchao; Li, Fangzhou; Xu, Yihui; Zhang, Linlin; Wang, Jinjin; Ni, Qiankun; Gan, Yaling; Gu, Chaojiang; Jiang, Huaidong; Huang, Xingxu; Shi, Xinghua; Zhang, Tongcun; Wu, Yan*; Liang, Xing-Jie*Nature Biomedical Engineering, 2023, 7(9).被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Advanced Materials
发表日期
2023-10-18
DOI
10.1002/adma.202309667
语言
ENGLISH
成果收录
SCIE
资助标注
Y.Z. and L.J. contributed equally to this work. This work was supported by the National Key Ramp;D Program of China (2022YFA1205700), the National Natural Science Foundation of China (U22A20156, 52173121), and the Science and Technology Program of Guangzh [2022YFA1205700]; National Key Ramp;D Program of China [U22A20156, 52173121]; National Natural Science Foundation of China [202103030004, 2017007]; Science and Technology Program of Guangzhou

作者

  • Z

    Zhu, Yueqiang (第一作者)

  • J

    Jin, Liangjie

查看全部 6 位作者收起作者
  • C

    Chen, Junbin

  • S

    Su, Miao

  • S

    Sun, Tianmeng

    1 · jilin univ

  • Y

    Yang, Xianzhu (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417